PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.05%
Net income growth under 50% of MRVL's 120.09%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
11.83%
D&A growth well above MRVL's 11.18%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-20.59%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-193.15%
Negative yoy working capital usage while MRVL is 194.47%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-74.86%
Negative yoy inventory while MRVL is 38.02%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-131.76%
Negative yoy usage while MRVL is 671.41%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-170.42%
Negative yoy while MRVL is 6.84%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-33.58%
Negative yoy CFO while MRVL is 562.36%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-41.52%
Both yoy lines negative, with MRVL at -86.44%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-80.47%
Both yoy lines negative, with MRVL at -84.44%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
57.85%
Similar to MRVL's 56.59%. Walter Schloss finds parallel timing in investment disposals or maturities.
No Data
No Data available this quarter, please select a different quarter.
-128.44%
Both yoy lines negative, with MRVL at -2349.62%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-70.57%
Negative yoy issuance while MRVL is 13.53%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-42.42%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.